Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyBone Marrow TransplantationCyclophosphamideStem Cell TransplantationHematopoietic Stem CellsMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsGraft SurvivalStem CellsTreatment OutcomeLymphoma, Non-HodgkinBone MarrowEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceHematopoiesisCarmustineIfosfamideBone Marrow CellsCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyVincristineTransplantation ChimeraTissue DonorsCytarabineAmyloidosisDisease-Free SurvivalHodgkin DiseaseWhole-Body IrradiationRetrospective StudiesNeoplasmsSurvival RateBlood Cell CountHistocompatibilityBlood CellsInfectionTime FactorsPlatelet CountSurvival AnalysisPOEMS SyndromeBone Marrow PurgingHistocompatibility TestingDoxorubicinImmunosuppressive AgentsLeukemiaLymphoma, T-CellLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabineRecombinant ProteinsCarboplatinPrednisoneBone Marrow DiseasesLymphomaDexamethasoneFollow-Up StudiesCytomegalovirus InfectionsAnemia, AplasticImmunophenotypingFeasibility StudiesAntineoplastic AgentsProspective StudiesGraft vs Leukemia EffectFatal OutcomeMyelodysplastic SyndromesLeukocytes, MononuclearBlood DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationFlow CytometryLymphocyte DepletionT-LymphocytesHematologic DiseasesHistiocytosis, Non-Langerhans-CellLeukocyte CountEmbryonic Stem CellsCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunomagnetic SeparationBone and BonesAntigens, CDOpportunistic Infections